Type 19 Pneumococcal Meningitis: A Patient With 75-Year Clinical and Serologic Follow Up, With a Review of the Evolution of Therapy From Antiserum to Sulfonamides to Penicillin.
Virginia H. Rogers Professor of Pediatric Infectious Diseases, Northwestern University, Feinberg School of Medicine Ann & Robert H. Lurie Children's Hospital of Chicago, Illinois.
Stanford T
ST
Shulman
D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000266:history / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000097:blood; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology*; D008586:Meningitis, Pneumococcal / Q000188:drug therapy*; D010406:Penicillins / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D007106:Immune Sera; D010406:Penicillins; D013449:Sulfonamides